
During a prospective study in post transfusion hepatitis 222 blood units were given to 55 patients who underwent open heart surgery. Eleven of these blood units contained anti-HBs titered higher than 1:128 by passive hemagglutination and were given to 10 patients previously negative for anti-HBs. Eight of these 10 patients showed anti-HBs in the first serum sample obtained usually one to three days after surgery and a continuous decline in titre was noted at later bleedings until antibodies were no longer detectable 2 to 20 weeks after transfusion. In four patients from whom regular blood samples were available the half life of passively acquired anti-HBs was determined to be between 23 and 28 days. In two patients with serum anti-HBs before blood transfusion no change in antibody titre was noted over a period of six months.
Time Factors, Humans, Blood Transfusion, Prospective Studies, Hepatitis B Antibodies, Hepatitis B, Immunity, Maternally-Acquired, Antibodies, Half-Life
Time Factors, Humans, Blood Transfusion, Prospective Studies, Hepatitis B Antibodies, Hepatitis B, Immunity, Maternally-Acquired, Antibodies, Half-Life
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
